RBD vaccine candidate (recombinant protein) for SARS-CoV-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RBD vaccine candidate (recombinant protein) for SARS-CoV-2, covering 2023-03-01 to 2023-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19) [Phase 1, Phase 2]